Acute mountain sickness: pathophysiology, prevention, and treatment.
暂无分享,去创建一个
Robert Roach | A. Subudhi | R. Roach | C. Imray | A. Wright | Chris Imray | Alex Wright | Andrew Subudhi
[1] J. P. Hannon,et al. Effects of acute high-altitude exposure on body fluids. , 1969, Federation proceedings.
[2] R. Panerai,et al. Acute hypoxia impairs dynamic cerebral autoregulation: results from two independent techniques. , 2009, Journal of applied physiology.
[3] P. Wagner,et al. Effect of acetazolamide on pulmonary and muscle gas exchange during normoxic and hypoxic exercise , 2007, The Journal of physiology.
[4] G. Kamimori,et al. Improvement in hypoxemia at 4600 meters of simulated altitude with carbohydrate ingestion. , 1999, Aviation, space, and environmental medicine.
[5] J. Serra,et al. Ginkgo biloba Decreases Acute Mountain Sickness in People Ascending to High Altitude at Ollagüe (3696 m) in Northern Chile , 2007, Wilderness & environmental medicine.
[6] R. Roach,et al. Acute ventilatory response to simulated altitude, normobaric hypoxia, and hypobaria. , 1996, Aviation, space, and environmental medicine.
[7] U. Scherrer,et al. Effects of high-altitude exposure on vascular endothelial growth factor levels in man , 2001, European Journal of Applied Physiology.
[8] M. Yaron,et al. How well do older persons tolerate moderate altitude? , 1995, The Western journal of medicine.
[9] B. Stone,et al. Altitude insomnia: studies during an expedition to the Himalayas. , 1988, Sleep.
[10] B. Levine,et al. Effect of hypoxic "dose" on physiological responses and sea-level performance. , 2007, Medicine and science in sports and exercise.
[11] M. Hamlin,et al. Game performance and intermittent hypoxic training , 2007, British Journal of Sports Medicine.
[12] L. Moore,et al. Acute Mountain Sickness in a General Tourist Population at Moderate Altitudes , 1993, Annals of Internal Medicine.
[13] R. Ross. THE RANDOM NATURE OF CEREBRAL MOUNTAIN SICKNESS , 1985, The Lancet.
[14] P. Chase,et al. Obesity: Associations with Acute Mountain Sickness , 2003, Annals of Internal Medicine.
[15] M. Serrano-Dueñas. High Altitude Headache. A Prospective Study of its Clinical Characteristics , 2005, Cephalalgia : an international journal of headache.
[16] V. M. Sharma,et al. Amelioration of acute mountain sickness: Comparative study of acetazolamide and spironolactone , 1986, International journal of biometeorology.
[17] R. Koehler,et al. 6 – Neural Control of the Circulation during Hypoxia , 1980 .
[18] T. Seto,et al. Ginkgo biloba for the prevention of severe acute mountain sickness (AMS) starting one day before rapid ascent. , 2002, High altitude medicine & biology.
[19] G. Skrinar,et al. Seven intermittent exposures to altitude improves exercise performance at 4300 m. , 2008, Medicine and science in sports and exercise.
[20] P. Hackett. The cerebral etiology of high-altitude cerebral edema and acute mountain sickness , 1999, Wilderness & environmental medicine.
[21] P. Goadsby. PATHOPHYSIOLOGY OF MIGRAINE , 2006, Neurologic clinics.
[22] W. Mills,et al. Dexamethasone for prevention and treatment of acute mountain sickness. , 1988, Aviation Space and Environmental Medicine.
[23] J. Jensen,et al. Cerebral Blood Flow Does Not Adapt to Sustained Hypoxia , 1990, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[24] Mark H. Wilson,et al. DIRECT MEASUREMENT OF INTRACRANIAL PRESSURE AT HIGH ALTITUDE AND CORRELATION OF VENTRICULAR SIZE WITH ACUTE MOUNTAIN SICKNESS: BRIAN CUMMINS' RESULTS FROM THE 1985 KISHTWAR EXPEDITION , 2008, Neurosurgery.
[25] J. Severinghaus. Hypothetical roles of angiogenesis, osmotic swelling, and ischemia in high-altitude cerebral edema. , 1995, Journal of applied physiology.
[26] Kevin Giblin,et al. Acute mountain sickness in a general tourist population at moderate altitudes , 1993 .
[27] Allen Cymerman,et al. Intermittent altitude exposures reduce acute mountain sickness at 4300 m. , 2004, Clinical science.
[28] P. Hackett,et al. Acetazolamide in the Treatment of Acute Mountain Sickness: Clinical Efficacy and Effect on Gas Exchange , 1992, Annals of Internal Medicine.
[29] B. Kayser,et al. Magnesium for the prevention and treatment of acute mountain sickness. , 2004, Clinical science.
[30] M. Tramèr,et al. Efficacy and harm of pharmacological prevention of acute mountain sickness: quantitative systematic review , 2000, BMJ : British Medical Journal.
[31] B. Tufts,et al. The structure and function of carbonic anhydrase isozymes in the respiratory system of vertebrates , 2006, Respiratory Physiology & Neurobiology.
[32] L. Garske,et al. Acetazolamide reduces exercise capacity and increases leg fatigue under hypoxic conditions. , 2003, Journal of applied physiology.
[33] M. Serrano-Dueñas. High-altitude headache , 2007, Expert review of neurotherapeutics.
[34] E. Ringelstein,et al. Relationship of cerebral blood flow regulation to acute mountain sickness. , 1989, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.
[35] W. Brechue,et al. Normoxic and acute hypoxic exercise tolerance in man following acetazolamide. , 1990, Medicine and science in sports and exercise.
[36] J. Milledge,et al. High altitude headache: treatment with ibuprofen. , 1994, Aviation, space, and environmental medicine.
[37] C. Peterson. Acetazolamide in the treatment of acute mountain sickness: Clinical efficacy and effect on gas exchange: Grissom CK, Roach RC, Sarnquist FH, et al Ann Intern Med 116:461–465 Mar 1992 , 1992 .
[38] T. H. Bavenhill. Some Experiences of Mountain Sickness in the Andes. , 1913 .
[39] T. Balkin,et al. Effect of high terrestrial altitude and supplemental oxygen on human performance and mood. , 1992, Aviation, space, and environmental medicine.
[40] B. Levine,et al. Dexamethasone in the treatment of acute mountain sickness. , 1989, The New England journal of medicine.
[41] M. Yaron,et al. Treatment of acute mountain sickness: hyperbaric versus oxygen therapy. , 1991, Annals of emergency medicine.
[42] F Lofaso,et al. Effect of zolpidem on sleep and ventilatory patterns at simulated altitude of 4,000 meters. , 1996, American journal of respiratory and critical care medicine.
[43] A. Cymerman,et al. The effect of altitude pre-acclimatization on acute mountain sickness during reexposure. , 1995, Aviation, space, and environmental medicine.
[44] M. MacDougall,et al. Change in plasma vascular endothelial growth factor during onset and recovery from acute mountain sickness. , 2007, Respiratory medicine.
[45] E. Swenson,et al. Prevention of acute mountain sickness by acetazolamide: as yet an unfinished story. , 2007, Journal of applied physiology.
[46] Effect of magnesium, high altitude and acute mountain sickness on blood flow velocity in the middle cerebral artery. , 2004, Clinical science.
[47] A. Bradwell,et al. Carbonic anhydrase inhibition in the immediate therapy of acute mountain sickness , 1994 .
[48] P. Sonnenberg,et al. Clinical features of headache at altitude , 2003, Neurology.
[49] K. Bloch,et al. Both Tadalafil and Dexamethasone May Reduce the Incidence of High-Altitude Pulmonary Edema , 2006, Annals of Internal Medicine.
[50] P. Boesiger,et al. Hypoxia-Induced Acute Mountain Sickness is Associated with Intracellular Cerebral Edema: A 3 T Magnetic Resonance Imaging Study , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[51] A. Bradwell,et al. Methazolamide and acetazolamide in acute mountain sickness. , 1983, Aviation Space and Environmental Medicine.
[52] J. West. Improving oxygenation at high altitude: acclimatization and O2 enrichment. , 2003, High altitude medicine & biology.
[53] P. Hackett,et al. High altitude cerebral edema. , 2004, High altitude medicine & biology.
[54] P. Bärtsch,et al. Ataxia in acute mountain sickness does not improve with short-term oxygen inhalation. , 2002, High altitude medicine & biology.
[55] W. Haefeli,et al. Cytochrome P450 enzyme-mediated drug metabolism at exposure to acute hypoxia (corresponding to an altitude of 4,500 m) , 2005, European Journal of Clinical Pharmacology.
[56] J. Stradling,et al. Temazepam at high altitude reduces periodic breathing without impairing next‐day performance: a randomized cross‐over double‐blind study , 2006, Journal of sleep research.
[57] A-K Dubey,et al. Ginkgo biloba--an appraisal. , 2004, Kathmandu University medical journal.
[58] Forster Pj. Effect of different ascent profiles on performance at 4,200 m elevation. , 1985 .
[59] D. Subedi,et al. Prevention of Acute Mountain Sickness by Acetazolamide in Nepali Porters: A Double-Blind Controlled Trial , 2006, Wilderness & environmental medicine.
[60] Charles D. Barnes,et al. Neural control of circulation , 1980 .
[61] Thomas G. Smith,et al. Effects of iron supplementation and depletion on hypoxic pulmonary hypertension: two randomized controlled trials. , 2009, JAMA.
[62] C. Sartori,et al. New insights in the pathogenesis of high-altitude pulmonary edema. , 2010, Progress in cardiovascular diseases.
[63] K. Bloch,et al. Effect of ascent protocol on acute mountain sickness and success at Muztagh Ata, 7546 m. , 2009, High altitude medicine & biology.
[64] M. Manyak,et al. High-Altitude Medicine , 2019, Travel Medicine.
[65] Charles S. Houston,et al. THE LAKE-LOUISE ACUTE MOUNTAIN-SICKNESS SCORING SYSTEM , 1993 .
[66] J. Remmers,et al. Hypoxia: The Adaptations , 1988 .
[67] S. Teng,et al. Animal Models of Acute Moderate Hypoxia Are Associated with a Down-Regulation of CYP1A1, 1A2, 2B4, 2C5, and 2C16 and Up-Regulation of CYP3A6 and P-glycoprotein in Liver , 2007, Drug Metabolism and Disposition.
[68] P. D'arbigny,et al. EGb 761 in control of acute mountain sickness and vascular reactivity to cold exposure. , 1996, Aviation, space, and environmental medicine.
[69] G. Skrinar,et al. Intermittent altitude exposures improve muscular performance at 4,300 m. , 2003, Journal of applied physiology.
[70] A. Cymerman,et al. The Effects of Propranolol on Acute Mountain Sickness (AMS) and Well- Being at 4300 Meters Altitude , 1989 .
[71] Bernhard Wn,et al. Acetazolamide plus low-dose dexamethasone is better than acetazolamide alone to ameliorate symptoms of acute mountain sickness. , 1998 .
[72] A. Roessler,et al. Role of hypobaria in fluid balance response to hypoxia. , 2005, High altitude medicine & biology.
[73] Scott A Gallagher,et al. High-altitude illness. , 2001, The New England journal of medicine.
[74] P. Lichter. Reducing side effects of carbonic anhydrase inhibitors. , 1981, Ophthalmology.
[75] E. Swenson,et al. Acute mountain sickness is not altered by a high carbohydrate diet nor associated with elevated circulating cytokines. , 1997, Aviation, space, and environmental medicine.
[76] A. Pollard. ALTITUDE INDUCED ILLNESS : IF IN DOUBT GO DOWN , 1992 .
[77] W. Nachbauer,et al. Effects of Aspirin During Exercise on the Incidence of High‐Altitude Headache: A Randomized, Double‐Blind, Placebo‐Controlled Trial , 2001, Headache.
[78] P. Golja,et al. Carbohydrate ingestion improves oxygen delivery in acute hypoxia. , 2008, High altitude medicine & biology.
[79] E. Swenson. Carbonic anhydrase inhibitors and hypoxic pulmonary vasoconstriction , 2006, Respiratory Physiology & Neurobiology.
[80] P. Bärtsch,et al. Determinants of acute mountain sickness and success on Mount Aconcagua (6962 m). , 2005, High altitude medicine & biology.
[81] T. Maren,et al. The activity of sulfonamides and anions against the carbonic anhydrases of animals, plants, and bacteria. , 1983, Annual review of pharmacology and toxicology.
[82] J. Krasney. A neurogenic basis for acute altitude illness. , 1994, Medicine and science in sports and exercise.
[83] P. Hackett,et al. Frontiers of hypoxia research: acute mountain sickness. , 2001, The Journal of experimental biology.
[84] B. Kayser,et al. Reduced incidence and severity of acute mountain sickness in Qinghai-Tibet railroad construction workers after repeated 7-month exposures despite 5-month low altitude periods. , 2009, High altitude medicine & biology.
[85] Mo Amdur. Effects of inhalation of sulfur dioxide by man , 1953 .
[86] K. Kubo,et al. Low pulmonary diffusing capacity in subjects with acute mountain sickness. , 1997, Chest.
[87] P. Hackett,et al. Ginkgo biloba for prevention of acute mountain sickness: does it work? , 2009, High altitude medicine & biology.
[88] E. Swenson,et al. Hypoxic ventilatory response, ventilation, gas exchange, and fluid balance in acute mountain sickness. , 2002, High altitude medicine & biology.
[89] P. Hackett,et al. ACUTE MOUNTAIN SICKNESS , 1977, The Lancet.
[90] J. Bittel,et al. Positive end expiratory pressure as a method for preventing acute mountain sickness , 1997, European Journal of Applied Physiology and Occupational Physiology.
[91] M. Raichle,et al. EFFECT OF CARBON DIOXIDE IN ACUTE MOUNTAIN SICKNESS: A REDISCOVERY , 1988, The Lancet.
[92] G. Lu,et al. Role of Excitatory Amino Acids in Hypoxic Preconditioning , 1999, Neurosignals.
[93] R. Wilson. Acute high-altitude illness in mountaineers and problems of rescue. , 1973, Annals of internal medicine.
[94] T. Maren,et al. Carbonic anhydrase: chemistry, physiology, and inhibition. , 1967, Physiological reviews.
[95] Hansen Je,et al. A hypothesis regarding the pathophysiology of acute mountain sickness. , 1970 .
[96] J. Anholm,et al. Ginkgo biloba and acetazolamide prophylaxis for acute mountain sickness: a randomized, placebo-controlled trial. , 2005, Archives of internal medicine.
[97] Exercise exacerbates acute mountain sickness at simulated high altitude. , 2000 .
[98] R. Wilber. Live high + train low: thinking in terms of an optimal hypoxic dose. , 2007 .
[99] D. Bailey,et al. Acute mountain sickness; prophylactic benefits of antioxidant vitamin supplementation at high altitude. , 2001, High altitude medicine & biology.
[100] A. Luks. Which medications are safe and effective for improving sleep at high altitude? , 2008, High altitude medicine & biology.
[101] E. Swenson. Carbonic anhydrase inhibitors and ventilation: a complex interplay of stimulation and suppression. , 1998, The European respiratory journal.
[102] Cyrill Burger,et al. Changes of Cerebral Blood Flow during Short-Term Exposure to Normobaric Hypoxia , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[103] R. M. Peters,et al. Acetazolamide and exercise in sojourners to 6,300 meters--a preliminary study. , 1985, Medicine and science in sports and exercise.
[104] S. Loft,et al. Acute hypoxia and cytochrome P450–mediated hepatic drug metabolism in humans , 2002, Clinical pharmacology and therapeutics.
[105] J. Rigg,et al. Effect of acetazolamide on hypoxemia during sleep at high altitude. , 1979, The New England journal of medicine.
[106] B. Basnyat,et al. Randomised, double blind, placebo controlled comparison of ginkgo biloba and acetazolamide for prevention of acute mountain sickness among Himalayan trekkers: the prevention of high altitude illness trial (PHAIT) , 2004, BMJ : British Medical Journal.
[107] J. Pandit. Altitude induced illness. , 1992, BMJ.
[108] Andries D. Bosch,et al. Cerebral Autoregulation in Subjects Adapted and Not Adapted to High Altitude , 2000, Stroke.
[109] J. Olesen,et al. Plasma levels of substance P, neuropeptide Y and vasoactive intestinal polypeptide in patients with chronic tension-type headache , 1999, PAIN®.
[110] V. Aoki,et al. Body hydration and the incidence and severity of acute mountain sickness. , 1971, Journal of applied physiology.
[111] P. Hackett,et al. Prophylactic low-dose acetazolamide reduces the incidence and severity of acute mountain sickness. , 2008, High altitude medicine & biology.
[112] K. Burgess,et al. Acute mountain sickness is associated with sleep desaturation at high altitude , 2004, Respirology.
[113] P. Bartsch,et al. Acute mountain sickness: influence of susceptibility, preexposure, and ascent rate. , 2002, Medicine and science in sports and exercise.
[114] H. Hautmann,et al. Theophylline improves acute mountain sickness. , 2000, The European respiratory journal.
[115] M. Moskowitz,et al. High altitude headache. Lessons from headaches at sea level. , 1999, Advances in experimental medicine and biology.
[116] P. Bärtsch,et al. Comparison of carbon-dioxide-enriched, oxygen-enriched, and normal air in treatment of acute mountain sickness , 1990, The Lancet.
[117] Jacob E. Barkley,et al. Catecholamine levels in hypoxia-lnduced acute mountain sickness. , 2009, Aviation, space, and environmental medicine.
[118] A. Richardson,et al. Hydration and the Physiological Responses to Acute Normobaric Hypoxia , 2009, Wilderness & environmental medicine.
[119] E. Swenson,et al. Acetazolamide 125 mg BD is not significantly different from 375 mg BD in the prevention of acute mountain sickness: the prophylactic acetazolamide dosage comparison for efficacy (PACE) trial. , 2006, High altitude medicine & biology.
[120] M. Maggiorini,et al. Simulated descent v dexamethasone in treatment of acute mountain sickness: a randomised trial , 1995, BMJ.
[121] R. Clayton,et al. Medroxyprogesterone at High Altitude. The Effects on Blood Gases, Cerebral Regional Oxygenation, and Acute Mountain Sickness , 2004, Wilderness & environmental medicine.
[122] P. Hackett,et al. THE INCIDENCE, IMPORTANCE, AND PROPHYLAXIS OF ACUTE MOUNTAIN SICKNESS , 1976, The Lancet.
[123] R L Burse,et al. Procedures for the measurement of acute mountain sickness. , 1983, Aviation, space, and environmental medicine.
[124] P. Hackett,et al. Ginkgo biloba Does—and Does Not—Prevent Acute Mountain Sickness , 2009, Wilderness & environmental medicine.
[125] W. Henderson,et al. Leukotriene receptor blockade does not prevent acute mountain sickness induced by normobaric hypoxia. , 2007, High altitude medicine & biology.
[126] A. Bradwell,et al. EFFECT OF ACETAZOLAMIDE ON EXERCISE PERFORMANCE AND MUSCLE MASS AT HIGH ALTITUDE , 1986, The Lancet.
[127] A. Young,et al. Effect of spironolactone on acute mountain sickness. , 1986, Aviation, space, and environmental medicine.
[128] D. Wagner,et al. Reliability and utility of a visual analog scale for the assessment of acute mountain sickness. , 2007, High altitude medicine & biology.
[129] G. Dubowitz. Effect of temazepam on oxygen saturation and sleep quality at high altitude: randomised placebo controlled crossover trial , 1998, BMJ.
[130] L. Moore,et al. Low acute hypoxic ventilatory response and hypoxic depression in acute altitude sickness. , 1986, Journal of applied physiology.
[131] R. C. Sawhney,et al. Glucocorticoids as prophylaxis against acute mountain sickness , 2002, Clinical endocrinology.
[132] P. Palange,et al. Relationship between individual ventilatory response and acute renal water excretion at high altitude , 2008, Respiratory Physiology & Neurobiology.
[133] Thomas G. Smith,et al. The increase in pulmonary arterial pressure caused by hypoxia depends on iron status , 2008, The Journal of physiology.
[134] Arthur R. Bradwell,et al. Effect of sildenafil and acclimatization on cerebral oxygenation at altitude. , 2005, Clinical science.
[135] E. Swenson,et al. A dose-response study of acetazolamide for acute mountain sickness prophylaxis in vacationing tourists at 12,000 feet (3630 m). , 2004, High altitude medicine & biology.
[136] Uwe Christians,et al. Greater free plasma VEGF and lower soluble VEGF receptor-1 in acute mountain sickness. , 2005, Journal of applied physiology.
[137] R. Roach,et al. Acute mountain sickness and acetazolamide. Clinical efficacy and effect on ventilation. , 1982, JAMA.
[138] P. Bärtsch,et al. Enhanced cerebral blood flow in acute mountain sickness. , 1994, Aviation, space, and environmental medicine.
[139] Thomas F. Hornbein,et al. Cerebral Blood Flow In Man at High Altitude: Role of Cerebrospinal Fluid pH in Normalization of Flow in Chronic Hypocapnia , 1966, Circulation research.
[140] M. Coleman,et al. Hypoxia, hypoxia-inducible factors (HIF), HIF hydroxylases and oxygen sensing , 2009, Cellular and Molecular Life Sciences.
[141] J. Launay,et al. Prevention of acute mountain sickness by low positive end-expiratory pressure in field conditions. , 2004, Scandinavian journal of work, environment & health.
[142] D. Leaf,et al. Mechanisms of action of acetazolamide in the prophylaxis and treatment of acute mountain sickness. , 2007, Journal of applied physiology.
[143] Michael J. Taylor,et al. Six percent oxygen enrichment of room air at simulated 5,000 m altitude improves neuropsychological function. , 2000, High altitude medicine & biology.
[144] B. Kayser,et al. Treatment of acute mountain sickness by simulated descent: a randomised controlled trial. , 1993, BMJ.
[145] D. Webb,et al. Oral antioxidant supplementation does not prevent acute mountain sickness: double blind, randomized placebo-controlled trial. , 2009, QJM : monthly journal of the Association of Physicians.
[146] Masafumi Kitakaze,et al. ER stress in cardiovascular disease. , 2010, Journal of molecular and cellular cardiology.
[147] S. Salimi,et al. Low-Dose Gabapentin in Treatment of High-Altitude Headache , 2007, Cephalalgia : an international journal of headache.
[148] M. Sander,et al. Sympathetic neural overactivity in healthy humans after prolonged exposure to hypobaric hypoxia , 2003, The Journal of physiology.
[149] H. Hinghofer-Szalkay,et al. Ventilation during simulated altitude, normobaric hypoxia and normoxic hypobaria. , 1997, Respiration physiology.
[150] S. Kriemler,et al. Successful treatment of acute mountain sickness with dexamethasone. , 1987, British medical journal.
[151] K. Pattinson,et al. Effect of exercise on cerebral perfusion in humans at high altitude. , 2005, Journal of applied physiology.
[152] K. Kubo,et al. Symptoms of acute mountain sickness in Sherpas exposed to extremely high altitude. , 2006, High altitude medicine & biology.
[153] A. Dahan,et al. Antioxidants reverse depression of the hypoxic ventilatory response by acetazolamide in man , 2006, The Journal of physiology.
[154] P. Hackett,et al. Arterial oxygen saturation for prediction of acute mountain sickness. , 1998, Aviation, space, and environmental medicine.
[155] M. Brooks. Methylene blue, an antidote to altitude sickness. , 1948, The Journal of aviation medicine.
[156] K. Kallenberg,et al. Magnetic Resonance Imaging Evidence of Cytotoxic Cerebral Edema in Acute Mountain Sickness , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[157] Q. Pittman,et al. Effects of acute hypoxia and hyperthermia on the permeability of the blood-brain barrier in adult rats. , 2009, Journal of applied physiology.
[158] L. Ried,et al. Acetazolamide or dexamethasone for prevention of acute mountain sickness: a meta-analysis , 1994 .
[159] C. Houston,et al. CEREBRAL FORM OF HIGH-ALTITUDE ILLNESS , 1975, The Lancet.
[160] A. Cymerman,et al. Dexamethasone as prophylaxis for acute mountain sickness. Effect of dose level. , 1989, Chest.
[161] A. Cymerman,et al. Exercise performance of sea-level residents at 4300 m after 6 days at 2200 m. , 2009, Aviation, space, and environmental medicine.
[162] J. Maher,et al. Prevention of acute mountain sickness by dexamethasone. , 1984, The New England journal of medicine.
[163] G. Gray,et al. Control of acute mountain sickness. , 1971, Aerospace medicine.
[164] R. Huber,et al. Theophylline and acetazolamide reduce sleep-disordered breathing at high altitude , 2004, European Respiratory Journal.
[165] I. Spyridopoulos,et al. Acute mountain sickness is not related to cerebral blood flow: a decompression chamber study. , 1999, Journal of applied physiology.
[166] N. Voelkel,et al. Plasma vascular endothelial growth factor in acute mountain sickness. , 2000, Chest.
[167] Low-dose acetylsalicylic acid analog and acetazolamide for prevention of acute mountain sickness. , 2008, High altitude medicine & biology.
[168] I. Singh,et al. Acute mountain sickness. , 1969, The New England journal of medicine.
[169] P. Hackett,et al. Medical therapy of altitude illness. , 1987, Annals of emergency medicine.
[170] R. I. Gamow,et al. A self-contained life support system designed for use with a portable hyperbaric chamber. , 1989, Biomedical sciences instrumentation.
[171] K. Strohl,et al. Low-dose theophylline reduces symptoms of acute mountain sickness. , 2008, Journal of travel medicine.
[172] C. W. Harris,et al. Effects of altitude acclimatization on blood composition of women. , 1969, Journal of applied physiology.
[173] S. Salimi,et al. Sumatriptan for prevention of acute mountain sickness: randomized clinical trial , 2007, Annals of neurology.
[174] M. A. Nerín,et al. Acute Mountain Sickness: Influence of Fluid Intake , 2006, Wilderness & environmental medicine.
[175] R. Panerai,et al. Effects of Hypobaric Hypoxia on Cerebral Autoregulation , 2010, Stroke.
[176] P. Curtis. Letter: Medicine by remote control. , 1973, Lancet.
[177] W. Schmidt,et al. Long-term intermittent hypoxia increases O2-transport capacity but not VO2max. , 2007, High altitude medicine & biology.
[178] W. Nachbauer,et al. Aspirin for prophylaxis against headache at high altitudes: randomised, double blind, placebo controlled trial , 1998, BMJ.
[179] J B West,et al. Barometric pressures on Mt. Everest: new data and physiological significance. , 1999, Journal of applied physiology.